BNP in septic patients without systolic myocardial dysfunction

Area of Science:

• Cardiology
• Critical Care Medicine
• Biochemistry

Background:

• Sepsis and septic shock are critical conditions where cardiac involvement is a concern.
• Brain natriuretic peptide (BNP) is often used to assess cardiac function, but its role in sepsis is debated.
• This study investigates whether elevated BNP in sepsis is primarily due to inflammation or left ventricular dysfunction.

Purpose of the Study:

• To determine the relationship between serum BNP levels and inflammatory markers in sepsis patients.
• To assess the correlation between BNP levels and left ventricular function in sepsis.
• To evaluate the predictive value of BNP for mortality in sepsis.

Main Methods:

• Twenty-one sepsis or septic shock patients were enrolled.
• Echocardiography was performed to assess left ventricular function.
• Serum concentrations of BNP, IL-1beta, IL-6, TNFalpha, and C-reactive protein (CRP) were measured.

Main Results:

• BNP levels positively correlated with CRP and IL-1 levels across different time points.
• No significant difference in BNP levels was observed between patients who survived and those who died.
• No clinical or echocardiographic evidence of left ventricular systolic dysfunction was found, suggesting BNP elevation is inflammation-driven.

Conclusions:

• Serum BNP is positively correlated with inflammatory markers (CRP, IL-1) in sepsis patients without left ventricular dysfunction.
• BNP levels were not associated with mortality in this cohort.
• BNP may be less accurate as a sole indicator of ventricular dysfunction in sepsis.